Mentioned Users

MyLungCancerTeam

Opdivo (Nivolumab) and Yervoy (Ipilimumab) are often prescribed together to treat metastatic non-small cell lung cancer. Here are some details:

Side Effects
Opdivo:
- Common: Fatigue, rash, musculoskeletal pain, itching, diarrhea, nausea, weakness, cough, shortness of breath, constipation, decreased appetite, back pain, Show Full Answer

Opdivo (Nivolumab) and Yervoy (Ipilimumab) are often prescribed together to treat metastatic non-small cell lung cancer. Here are some details:

Side Effects:
Opdivo:
- Common: Fatigue, rash, musculoskeletal pain, itching, diarrhea, nausea, weakness, cough, shortness of breath, constipation, decreased appetite, back pain, joint pain, fever, headache, abdominal pain, vomiting.
- Rare but serious: Fetal harm, infusion reactions.

Yervoy:
- Common: Fatigue, diarrhea, itching, rash, nausea, vomiting, headache, weight loss, fever, decreased appetite, insomnia.
- Rare but serious: Fetal harm, immune-mediated adverse reactions, infusion reactions.

Effectiveness:
- Opdivo and Yervoy work by enhancing the immune system's ability to identify and destroy cancer cells. However, specific information about their effectiveness in treating malignant pleural effusion is not provided in my knowledge base.

For more details, you can visit:
- [Opdivo — Bristol Myers Squibb](https://www.opdivo.com/)
- [Yervoy — Bristol Myers Squibb](https://www.yervoy.com/)

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Yervoy (Ipilimumab) for Lung Cancer | MyLungCancerTeam

Opdivo (Nivolumab) for Lung Cancer | MyLungCancerTeam